Prescription drug · NDA
Doxycycline NDC 85776-300
Doxycycline 150 mg/1 · Capsule · Oral · Wellhouse Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85776-300-60 | 85776030060 | 60 CAPSULE in 1 BOTTLE (85776-300-60)Marketed from Jul 21, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxycycline
- Generic name (nonproprietary)
- doxycycline
- Active ingredients
- Doxycycline — 150 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Wellhouse Pharma, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 050641
- Marketing start
- Listing expires
- Other FDA classes
- Tetracyclines (Chemical structure)
- Identifiers
- Product ID 85776-300_575c46be-1210-fb40-e063-6294a90a8d0fSPL ID 575c46be-1210-fb40-e063-6294a90a8d0fSPL set ID 57f97f68-11fb-4900-9efb-ca3b00818d8eRxCUI 728207UNII N12000U13OUPC 0385776300609
- Pharmacologic class
- Tetracycline-class Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485776030060followed by a unit qualifier and the quantityPackage 85776-0300-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky mountain spotted fever, typhus fever and the typhus gro…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 050641
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxycycline Monohydrate | Doxycycline 75 mg/1 | CapsuleOral | Chartwell RX, LLC. | 62135-261 |
| Doxycycline Monohydrate | Doxycycline 50 mg/1 | CapsuleOral | Chartwell RX, LLC. | 62135-260 |
| Doxycycline Monohydrate | Doxycycline 100 mg/1 | CapsuleOral | Chartwell RX, LLC. | 62135-262 |
| Doxycycline Monohydrate | Doxycycline 150 mg/1 | CapsuleOral | Chartwell RX, LLC. | 62135-263 |